Literature DB >> 10747766

The cost of urinary incontinence in Italian women. A cross-sectional study. Gruppo di Studio Incontinenza.

F Tediosi1, F Parazzini, A Bortolotti, L Garattini.   

Abstract

OBJECTIVE: To offer cost estimates of urinary incontinence (UI) in the general population based on prospectively collected data.
DESIGN: We analyzed individual costs in a sample of women with UI who were identified in the framework of a cross-sectional study on the prevalence of UI in women aged > 40 years.
SETTING: Six areas in Italy. INTERVENTION: Home interview. PATIENTS AND PARTICIPANTS: Women were identified among the patients registered with a network of general practitioners operating in each area using computer-generated random number lists.
RESULTS: A total of 2767 women were identified. Of these, 408 (14.7%) reported UI during the year before the interview and 229 underwent a detailed interview on UI-related costs. On the basis of this information, we estimated the direct costs associated with UI from the perspective of the Italian National Health Service (INHS). The lifetime cost per patient of diagnosis was 80,131 Italian lire (L) (exchange rate: $US1 = L1618). Consultations accounted for only 20% of the diagnostic cost, diagnostic tests for 36% and hospital admissions for diagnostic procedures accounted for 44%. The diagnosis cost estimate seems low, partly because several women did not request either consultations or diagnostic tests (the overall rate per patient was 0.76 for consultations and 0.39 for diagnostic tests). The only appreciable treatment cost, according to the INHS perspective, was for diapers. The annual cost per patient for diapers was L255,519. The prevalence of UI in women aged > 40 years in Italy is estimated in the study at 9.3%. Thus, combining this information with the cost estimates, the annual treatment cost of UI in Italian women aged > 40 years is L351,800 billion, considering diapers and drugs only.
CONCLUSION: This study has estimated the individual cost of UI in the general population. These figures may be useful when designing economic evaluations of UI.

Entities:  

Mesh:

Year:  2000        PMID: 10747766     DOI: 10.2165/00019053-200017010-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  12 in total

1.  The costs of urinary incontinence.

Authors:  C M Callahan
Journal:  Pharmacoeconomics       Date:  1994-08       Impact factor: 4.981

2.  Descriptive epidemiology of urinary incontinence in 3,100 women age 30-59.

Authors:  L B Elving; A Foldspang; G W Lam; S Mommsen
Journal:  Scand J Urol Nephrol Suppl       Date:  1989

Review 3.  Prevalence and incidence of urinary incontinence in community-dwelling populations.

Authors:  A R Herzog; N H Fultz
Journal:  J Am Geriatr Soc       Date:  1990-03       Impact factor: 5.562

4.  Impact of urinary incontinence on health-care costs.

Authors:  T W Hu
Journal:  J Am Geriatr Soc       Date:  1990-03       Impact factor: 5.562

5.  Urinary incontinence. Social and financial costs high.

Authors:  P Ekelund; A Grimby; I Milsom
Journal:  BMJ       Date:  1993-05-15

6.  Urge incontinence. Quality of life and patients' valuation of symptom reduction.

Authors:  R M O'Conor; M Johannesson; S L Hass; G Kobelt-Nguyen
Journal:  Pharmacoeconomics       Date:  1998-11       Impact factor: 4.981

Review 7.  The 'costs' of urinary incontinence.

Authors:  J F Wyman
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

8.  Urinary incontinence in the community--analysis of a MORI poll.

Authors:  J C Brocklehurst
Journal:  BMJ       Date:  1993-03-27

Review 9.  The role of patient history in the diagnosis of urinary incontinence.

Authors:  J K Jensen; F R Nielsen; D R Ostergard
Journal:  Obstet Gynecol       Date:  1994-05       Impact factor: 7.661

10.  Prevalence of urinary incontinence.

Authors:  T M Thomas; K R Plymat; J Blannin; T W Meade
Journal:  Br Med J       Date:  1980-11-08
View more
  6 in total

1.  Urinary incontinence management costs are reduced following Burch or sling surgery for stress incontinence.

Authors:  Leslee L Subak; Patricia S Goode; Linda Brubaker; John W Kusek; Michael Schembri; Emily S Lukacz; Stephen R Kraus; Toby C Chai; Peggy Norton; Sharon L Tennstedt
Journal:  Am J Obstet Gynecol       Date:  2014-03-11       Impact factor: 8.661

2.  Decrease in urinary incontinence management costs in women enrolled in a clinical trial of weight loss to treat urinary incontinence.

Authors:  Leslee L Subak; Angela Marinilli Pinto; Rena R Wing; Sanae Nakagawa; John W Kusek; William H Herman; Miriam Kuppermann
Journal:  Obstet Gynecol       Date:  2012-08       Impact factor: 7.661

Review 3.  Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations.

Authors:  Denis Getsios; Wissam El-Hadi; Ingrid Caro; J Jaime Caro
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  The "costs" of urinary incontinence for women.

Authors:  Leslee L Subak; Jeanette S Brown; Stephen R Kraus; Linda Brubaker; Feng Lin; Holly E Richter; Catherine S Bradley; Deborah Grady
Journal:  Obstet Gynecol       Date:  2006-04       Impact factor: 7.661

5.  High costs of urinary incontinence among women electing surgery to treat stress incontinence.

Authors:  Leslee L Subak; Linda Brubaker; Toby C Chai; Jennifer M Creasman; Ananias C Diokno; Patricia S Goode; Stephen R Kraus; John W Kusek; Wendy W Leng; Emily S Lukacz; Peggy Norton; Sharon Tennstedt
Journal:  Obstet Gynecol       Date:  2008-04       Impact factor: 7.661

Review 6.  Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review.

Authors:  Crisanta I Tapia; Kristin Khalaf; Karina Berenson; Denise Globe; Michael Chancellor; Lesley K Carr
Journal:  Health Qual Life Outcomes       Date:  2013-01-31       Impact factor: 3.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.